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ABSTRACT
The expression of the vast majority of protein coding
genes in trypanosomes is regulated exclusively
at the post-transcriptional level. Developmentally
regulated mRNAs that vary in levels of expression
have provided an insight into one mechanism of
regulation; a decrease in abundance is due to a
shortened mRNA half-life. The decrease in half-life
involves cis-acting elements in the 30 untranslated
region of the mRNA. The trans-acting factors neces-
sary for the increased rate of degradation remain
uncharacterized. The GPI-PLC gene in Trypanosoma
brucei encodes a phospholipase C expressed in
mammalian bloodstream form, but not in the insect
procyclic form. Here, it is reported that the differential
expression of the GPI-PLC mRNA also results from
a 10-fold difference in half-life. Second, the instability
of the GPI-PLC mRNA in procyclic forms can be
reversed by the inhibition of protein synthesis.
Third, specifically blocking the translation of the
GPI-PLC mRNA in procyclic forms by the inclusion
of a hairpin in the 50 untranslated region does not
result in stabilization of the mRNA. Thus, the effect
of protein synthesis inhibitors in stabilizing the
GPI-PLC mRNA operates in trans through a short-
lived factor dependent on protein synthesis.
INTRODUCTION
Protein coding genes in Trypanosoma brucei and other kin-
etoplastid protozoa are arranged in arrays (1,2) and tens of
genes are co-transcribed from distant promoters (3–7). Indi-
vidual mRNAs are monocistronic and are co-transcriptionally
processed from a pre-mRNA by two steps, a trans-splicing
reaction that adds a capped 39 base mini-exon (8) to the 50 end
of the mRNA and a cleavage and polyadenylation reaction
at the 30 end. The trans-splicing is functionally linked to the
polyadenylation of the 50 flanking mRNA (9–11). The trans-
splicing reaction is mechanistically similar to cis-splicing (12)
and orthologues of many of the factors required for poly-
adenylation in crown group eukaryotes are present in the gen-
omes of kinetoplastids (13), but the canonical AAUAAA motif
for the site of polyadenylation is not present.
With some exceptions, there does not appear to be extens-
ive clustering of genes into operon-like arrays of obviously
functionally linked genes. In contrast, mRNAs derived from
adjacent genes are often present at different levels and can
show different developmental expression patterns [see (14)
for an example]. In trypanosomes, there is regulation of
transcription of the two dominant developmentally regulated
cell surface proteins, the variant surface glycoprotein and
procyclin (15–18), but these are transcribed by RNA poly-
merase I and represent a special case (3,19–21). The vast
majority of the protein coding genes are transcribed by RNA
polymerase II and there is no definitive evidence for tran-
scriptional control of these genes (22). If adjacent genes are
transcribed at the same rate, then the regulation of indi-
vidual mRNA levels must be post-transcriptional. The
mechanism of post-transcriptional regulation that has attrac-
ted most investigation is mRNA half-life and especially the
involvement of regulation of half-life in differentially
expressed mRNAs that are more abundant in one life
cycle stage than in another (22). In trypanosomes, there
are two life cycle stages amenable to experimental manip-
ulation: the bloodstream form trypanosome, normally resid-
ent in a mammal, and the procyclic form present in the
insect midgut. The bloodstream form differentiates into
the procyclic form in the insect and the process can be
reproduced in culture (23). Most effort has concentrated
on mRNAs that are more abundant in procyclic forms
and the identification of the cis-acting sequences necessary
for instability in bloodstream forms (24–26). This work has
identified U-rich elements (UREs) within the 30UTR of three
mRNAs that are required for instability of these mRNAs in
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bloodstream forms (27,28). The pathways by which unstable
mRNAs are degraded have received less attention. There is
evidence for involvement of the exosome (29), a complex
of 30 to 50 exonucleases (30), and other nucleases as both
50 to 30 and 30 to 50 exonuclease intermediates have been
observed (31). The most striking inhibition of degradation
of unstable mRNAs occurred after inhibition of protein
synthesis; procyclic form-specific EP procyclin mRNA in
bloodstream form trypanosomes (32–34) and logarithmic
phase-specific GP63 mRNA in stationary phase Leishmania
chagasi promastigotes (35).
The GPI-PLC gene encodes a non-essential glycosylphos-
phatidylinositol-specific phospholipase C expressed in
bloodstream form, but not procyclic form trypanosomes
(36–38). The mRNA is moderately abundant in bloodstream
forms, but almost undetectable in procyclic forms (37,39),
and there is no difference in the transcription rate in the
two life cycle stages (39). In this paper, the differential
expression of GPI-PLC mRNA in the two life cycle stages
is investigated and it is shown that the developmental
regulation of steady-state mRNA levels is underpinned by
a 10-fold reduced half-life in procyclic forms. Inhibition of
protein synthesis causes a rapid stabilization of GPI-PLC
mRNA in procyclic forms resulting from an increase in
mRNA half-life. However, specifically blocking the trans-
lation of the GPI-PLC mRNA in procyclic forms does not
lead to stabilization of the mRNA. Thus, it is likely that the
stabilization of the GPI-PLC mRNA caused by inhibition of
protein synthesis results from the dissipation of a polypep-
tide with a very short half-life that is necessary for the
degradation of the unstable GPI-PLC mRNA in procyclic
forms.
MATERIALS AND METHODS
Trypanosomes
The stock Lister 427 was used throughout (40). Bloodstream
forms expressing either VSG MITat 1.5 (118) or MITat1.2
(221) were grown in culture in HMI-9 medium (41) containing
10% foetal bovine serum. In vitro differentiation of blood-
stream forms to procyclic forms was performed using DTM
with 15% foetal bovine serum containing 3 mM citrate and
3 mM cis-aconitate at 27C (23). Procyclic forms derived
in vitro from bloodstream forms were grown in DTM con-
taining 15% foetal bovine serum. Established procyclic form
cell lines (Lister 427) were grown in SDM-79 containing 10%
foetal bovine serum (42). For the tetracycline-inducible
expression of the GPI-PLC gene, Lister 427 procyclic forms
with the plasmids pLEW29 and pLEW13 integrated into the
tubulin locus (427 29-13) were used (43) (a gift from Professor
George Cross, Rockerfeller University). Sinefungin was
used at a final concentration of 2 mg/ml and cycloheximide
at 50 mg/ml, this latter concentration is sufficient for maximal
inhibition of [35S]-methionine incorporation into trichloro-
acetic acid precipitable material (44).
Transgenic trypanosomes
The over-expression of GPI-PLC mRNA in procyclics was
achieved using a plasmid derived from pLEW100 (43). First,
the EP procyclin 50UTR and luciferase gene were removed
using a complete BamHI and partial Xma1 digest and
replaced with a polylinker containing BstBI and HindIII
sites to produce p1865. Second, a ClaI HindIII fragment con-
taining all of the GPI-PLC gene (37) plus processing signals
for the flanking genes (Figure 4a) was cloned into the BstBI
and HindIII sites of p1865 to produce p1885. The plasmid
p1885 was linearized with NotI and electroporated into Lister
427 29-13 procyclic forms and integrants selected using
zeocin.
GPI-PLC / trypanosomes were generated from blood-
stream form trypanosomes expressing VSG MITat 1.5 using
constructs described previously (38) except that a bleomycin-
resistance gene was used in place of a neomycin-resistance
gene. The GPI-PLC gene was returned to the endogenous locus
using the construct shown in Figure 4b. The neomycin-
resistance cassette contained the EP1 procyclin mini-exon
addition signal and 50UTR, and the b-tubulin 30UTR and poly-
adenylation site. It was located 400 bp to the 30 side of the
putative GPI-PLC polyadenylation site.
Cell harvesting
For most experiments, cells—typically 10 ml of procyclic
form culture at 5 · 106 cells/ml—were harvested by cent-
rifugation at 1200 g for 7 min, the pellet was resuspended in
1 ml phosphate-buffered saline, transferred to an Eppendorf
tube and cells recovered by centrifugation at 8000 g for 30 s,
the supernatant was removed and the cell pellet lysed in
the appropriate buffer from the RNA preparation kit (see
below). This procedure took between 9 and 10 min from
culture to lysis. For the determination of GPI-PLC mRNA
half-life in procyclic cells (Figure 1c), cells were harvested
by centrifugation at 6000 g for 1 min, the supernatant
was aspirated away and the cell pellet lysed in the appro-
priate buffer from the kit. This procedure took 3 min from
culture to lysis.
For western blot analysis, cells were washed twice with 0.5
culture volumes of phosphate-buffered saline prior to lysis in
SDS–PAGE sample buffer (45).
RNA and protein analysis
RNA was prepared using the RNAeasy kit from Qiagen and
analysed using vertical agarose gels after denaturing the
RNA with glyoxal (46). Northern blotting was as described
in (47). After hybridization, all blots were washed in 15 mM
sodium chloride 1.5 mM trisodium citrate (0.1· SSC), 0.1%
sodium dodecyl sulphate at 60C. Routinely, blots were
probed sequentially for GPI-PLC, then a- and b-tubulin
sometimes including EP procyclin at the same time, then
rRNA. All time courses were performed twice and gave the
same results within the accuracy of the phosphorimager
measurements (see below).
SDS–PAGE (45) and western blots (48) were performed
using standard procedures.
Phosphorimager analysis
Data were collected using a Molecular Dynamics Storm
840 and analysed using the accompanying ImageQuant
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software. Individual bands were measured and background
subtracted. Loading differences were measured using the
signal from an rRNA overprobe of the same blot and
the mRNA signal adjusted for loading. The error in the
measurement procedure was estimated by comparing values
for the same sample loaded two or three times on the same
gel. The range of values fell within –15% of the mean
value.
Figure 1. Estimation of GPI-PLC mRNA half-life following inhibition of mRNA maturation with sinefungin. Northern blots showing decay of GPI-PLC mRNA
after sinefungin addition in (a) bloodstream forms and (b) procyclic forms and (c) transgenic procyclic forms expressing a GPI-PLC gene from a strong promoter. In
each case, the same blot was probed with a- and b-tubulin to show the sinefungin-dependent appearance of dicistronic tubulin mRNAs and then for an rRNA to
estimate comparative loading. The probe is indicated under each blot. The inset in panel (b) shows a five times longer exposure of region of the blots containing the
GPI-PLC mRNA. (d) The GPI-PLC mRNA and rRNA were quantitated in (a) and (c) using a phosphorimager and the GPI-PLC mRNA determined as a concentration
relative to the amount of rRNA. RNA size standards are shown in panels (a) and (b).
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RESULTS
A difference in mRNA half-life underlies the
developmentally regulated expression of
the GPI-PLC gene
Expression of the GPI-PLC gene is developmentally
regulated, the mRNA is readily detected in bloodstream
form trypanosomes, but is barely detectable in procyclic
forms (37). As the GPI-PLC gene is located in a presumed
polycistronic transcription unit on chromosome 2 (2) and is
flanked by two constitutively expressed genes HSP100 and
b’-COP (49,50), it appeared likely that the developmental
regulation of the GPI-PLC mRNA is post-transcriptional.
To test this, the half-life of the GPI-PLC mRNA in the two
developmental stages was estimated by determining the rate of
decay after blocking mRNA maturation using sinefungin,
which blocks methylation of the 50 cap on the mini-exon
donor RNA, thus inhibiting trans-splicing which in turn blocks
polyadenylation (9,11,51). Over the course of the experiments,
the sinefungin had no effect on cell motility and the cells
retained normal morphology as judged by phase contrast
microscopy. One effect of sinefungin was to cause an imme-
diate accumulation of incompletely processed tubulin mRNAs
as previously described (11), most visible as dicistronic RNAs
on the northern blot (Figure 1a). The use of sinefungin to
follow mRNA decay was used in preference to an inhibitor
of transcription, such as actinomycin D, as the point of action
in blocking mRNA maturation removes any need to consider
the fate of partially processed transcripts. The effect of sine-
fungin was very rapid and allowed the measurement of mRNA
half-lives of as little as 3 min (see below).
The major form of the GPI-PLC mRNA detected on north-
ern blots was 3.6 kb (Figure 1a). The half-life of the 3.6 kb
GPI-PLC mRNA was 30 – 5 min in bloodstream forms
(Figure 1d). In procyclic forms, the GPI-PLC mRNA was
detected only after a long exposure of the northern blot and
was absent at the 10 min sinefungin time point suggesting a
very short half-life (Figure 1b). The low steady-state levels in
procyclic forms made an estimate of the half-life technically
difficult, so a procyclic cell line with a GPI-PLC transgene
expressed from the strong EP procyclin promoter (43) was
produced with the aim of increasing the steady-state level of
the GPI-PLC mRNA at the beginning of the time course. In
addition, the cell harvesting procedure was altered so that cells
were lysed in 3 min from culture instead of the 10 min taken
in the previous experiments. The over-expression strategy
was successful and permitted the estimation of half-life
after addition of sinefungin (Figure 1c). The half-life of the
GPI-PLC mRNA was 3 – 1 min (Figure 1d). Thus, the half-
life of GPI-PLC mRNA is approximately 10-fold greater in
bloodstream forms than in procyclics.
Inhibition of protein synthesis in procyclic forms leads
to a rapid accumulation of GPI-PLC mRNA due to
an increase in half-life of the mRNA
Inhibition of protein synthesis in bloodstream form trypano-
somes leads to a rapid accumulation of the normally unstable
EP procyclin mRNA (32–34). A similar effect was observed
when procyclic forms were treated with cycloheximide and the
steady-state levels of GPI-PLC mRNA determined (Figure 2).
There was readily detectable accumulation 30 min after cyclo-
heximide addition, and the mRNA reached a steady-state level
after2 h. Asimilar stabilization of the GPI-PLC mRNAwas also
observed with anisomycin, another protein synthesis inhibitor
(data not shown). The effect of protein synthesis inhibitors
on the GPI-PLC mRNA was not a general phenomenon;
over the time course of cycloheximide treatment, the levels
of a- and b-tubulin mRNAs increased but less than 2-fold
whereas the levels of EP procyclin mRNA decreased (Figure 2).
Figure 2. Inhibition of protein synthesis results in the appearance of GPI-PLC mRNA. Northern blot showing a time course after the addition of cycloheximide. The
same blot was probed for EP procyclin and a- and b-tubulin to demonstrate that mRNA stabilization is not a general consequence of blocking translation and for an
rRNA to estimate comparative loading. The probe is indicated under each blot. The GPI-PLC mRNA and rRNA were quantitated using a phosphorimager, and the
GPI-PLC mRNA determined as a concentration relative to the amount of rRNA and is expressed in arbitrary units.
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The data from this experiment were also used to estimate the
ratio between the bloodstream and procyclic form steady-state
levels of GPI-PLC mRNA. The result, corrected for rRNA as a
measure of loading, was that the GPI-PLC mRNA is at 50-fold
higher levels in bloodstream than in procyclic forms. After
cycloheximide treatment, the difference was reduced to just
over 2-fold.
The half-life of GPI-PLC mRNA after inhibition of protein
synthesis treatment by incubation with cycloheximide for 2 h
was determined by addition of sinefungin and preparation of
RNA over an 80 min time course (Figure 3). At the end of the
time course, the cells had retained motility and appeared mor-
phologically normal by phase contrast microscopy. The sine-
fungin resulted in an accumulation of incompletely processed
tubulin mRNAs, again most visible as the dicistron on a north-
ern blot (Figure 3). The rate of accumulation of the tubulin
dicistron was similar to procyclic cells treated with sinefungin
without prior cycloheximide treatment (Figure 1b) suggesting
that the 2 h treatment with cycloheximide had little effect on
transcription. After addition of sinefungin, the half-life of the
GPI-PLC mRNA was 30 – 5 min. Thus, the inhibition of
protein synthesis had resulted in a 10-fold increase in the
half-life of the GPI-PLC mRNA in procyclic forms.
Blocking the translation of the GPI-PLC mRNA in
procyclic forms does not result in stabilization
The GPI-PLC gene is non-essential (38) and bloodstream
trypanosomes derived from the Lister 427 cell line with
both copies of the GPI-PLC gene deleted proliferate at the
same rate in culture as wild-type cells (52) (H. Webb and
M. Carrington, unpublished). The strategy used to specifically
block translation of the GPI-PLC mRNA was to reintroduce
versions of the GPI-PLC gene that could not be translated into
the endogenous locus of GPI-PLC null bloodstream trypano-
somes (Figure 4). The bloodstream trypanosomes were then
differentiated to procyclic forms in vitro and the steady-state
level of the GPI-PLC mRNA was compared in the two life
cycle stages.
To make the GPI-PLC null cell line, the entire GPI-PLC
mRNA coding sequence, including 50 and 30UTR, was
replaced with an antibiotic-resistance cassette. The two alleles
were replaced sequentially, first using a hygromycin and then a
bleomycin-resistance gene (Figure 4). Once the GPI-PLC
deletants had been verified, a range of wild-type and modified
GPI-PLC genes were returned to the locus (Figure 4b). The
re-introduction construct returned the entire GPI-PLC mRNA
coding sequence, restored the intergenic sequence to the 50 side
of the GPI-PLC gene and introduced a neomycin-resistance
cassette in the intergenic sequence between the GPI-PLC gene
and the downstream gene.
Three GPI-PLC genes were returned to the endogenous
locus: (i) a wild-type GPI-PLC gene as a control for expres-
sion; (ii) a GPI-PLC gene with a hairpin in the 50UTR; (iii) a
GPI-PLC gene containing a stop codon instead of codon 15 to
assay for nonsense-mediated decay of the GPI-PLC mRNA.
The hairpin added to the 50UTR contained 23 bp (Figure 4),
Figure 3. Estimation of the half-life of cycloheximide-induced GPI-PLC mRNA in procyclic forms. Cells were incubated with cycloheximide for 2 h, and then
sinefungin added and samples were taken over a time course and analysed by northern blotting. After probing for GPI-PLC, the same blot was probed with a- and
b-tubulin to show the sinefungin-dependent appearance of dicistronic tubulin mRNAs and then for an rRNA to estimate comparative loading. The probe is indicated
under each blot. The predominant GPI-PLC mRNA indicated with an arrow and rRNA were quantitated using a phosphorimager and the GPI-PLC mRNA
determined as a concentration relative to the amount of rRNA. RNA size standards are shown.
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and was based on constructs used in other systems that have
been shown to be sufficient to block translation (53).
The level of expression of GPI-PLC protein was determined
by western blotting bloodstream form clones containing a
transgene (Figure 5). A titration of wild-type cell lysate
was used to calibrate the sensitivity of the assay and on a
long exposure of the western blot, it was possible to detect
GPI-PLC when 1/80 of the cell equivalents of wild-type cells
(+/+) were loaded indicating that the assay was sensitive down
to 1% of wild-type levels. Expression from the wild-type
GPI-PLC transgene (/::GPI-PLC) was readily detected,
but no expression was detected from either the GPI-PLC
gene containing a hairpin in the 50UTR (/::GPI-PLC hair-
pin) or, as expected, from the GPI-PLC gene containing a
premature stop codon (/::GPI-PLC early stop)
(Figure 5). These results demonstrate that the hairpin in the
50UTR of the GPI-PLC mRNA blocked translation.
Each of the bloodstream trypanosome clones was differen-
tiated to procyclic forms in vitro and RNA prepared from both
life cycle stages for each clone. Two distinct clones containing
the GPI-PLC transgene with a 50UTR hairpin and two con-
taining a GPI-PLC transgene with a premature stop codon
were analysed. The level of the GPI-PLC mRNA was determ-
ined by northern blotting (Figure 6).
GPI-PLC mRNA was detected inall bloodstream formclones
containing a transgene. In all cases, the mRNAwas a similar size
(a)
(b)
Figure 4. (a) Diagram showing the GPI-PLC genomic locus which is flanked by the HSP100 and b0-COP genes (49) and the GPI-PLC gene replacement strategy.
The two major mRNAs are shown above the GPI-PLC gene with the mini-exon addition sites indicated by filled circles and the approximate location of
the polyadenylation site by a vertical line. The ClaI HindIII restriction enzyme fragment cloned into the expression vector p1865 is indicated. The starting cells
are GPI-PLC / and targeted insertion of a neoR gene results in the return of a GPI-PLC gene to the endogenous locus. (b) Sequence detail around the initiation
codon of the GPI-PLC showing the location and sequence of the hairpin introduced into the 50UTR and the location of the premature stop codon.
Figure 5. Expression of GPI-PLC protein from GPI-PLC transgenes returned
to the endogenous locus. The expression of GPI-PLC was tested in the parental
GPI-PLC / cell line and two independent clones of cell lines containing
transgenes encoding wild-type GPI-PLC or GPI-PLC with a hairpin in the
50UTR or GPI-PLC with a stop codon replacing codon 15. A titration of
2 · 106 (1 cell equivalent) to 2.5 · 104 bloodstream form cells (1/80 cell
equivalent) is shown as a measure of sensitivity. The antiserum used is indicated
under each blot, anti-ISG65 was used as a loading control.
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to that from GPI-PLC+/+cells and had the characteristic pattern
of two distinct mRNAs indicating that the transcript was cor-
rectly processed. The steady-state level of mRNA in the clone
containing the wild-type GPI-PLC transgene (/::GPI-PLC)
was less than in a heterozygote (+/). The only difference
between the transgene and the endogenous locus is the
antibiotic-resistance cassette to the 30 side of GPI-PLC gene,
which may affect the efficiency of polyadenylation of the GPI-
PLC mRNA. The steady-state level of GPI-PLC mRNA in
bloodstream forms with the transgene containing a premature
stop codon (/::GPI-PLC early stop) was similar to that from
the wild-type transgene indicating that there is little or no
nonsense-mediated decay of the GPI-PLC mRNA. There
were increased levels of the GPI-PLC mRNA in bloodstream
trypanosomes containing a transgene with a hairpin in the
50UTR (/::GPI-PLC hairpin) presumably due to interfer-
ence with the normal mRNA turnover pathway.
None of the transgenes produced a significant steady-state
level of GPI-PLC mRNA in the procyclic forms indicating that
the developmental regulation of GPI-PLC mRNA was still
operating for all the transgenes. Thus, specifically blocking
the translation of the GPI-PLC mRNA does not lead to sta-
bilization of the mRNA in procyclic forms.
DISCUSSION
The regulation of mRNA stability is the major level of regu-
lation of gene expression in trypanosomes. Developmentally
regulated mRNAs, such as GPI-PLC which is moderately
abundant in bloodstream trypanosomes, but almost absent
in procyclic forms, provide an opportunity to investigate
the regulation of stability. The major findings of this paper
are that (i) the half-life of the GPI-PLC mRNA is approxim-
ately 10-fold greater in bloodstream forms than in procyclic
forms; (ii) the inhibition of protein synthesis causes a rapid
stabilization of GPI-PLC mRNA in procyclic forms; (iii) the
stabilization of the GPI-PLC mRNA in procyclic forms after
inhibition of protein synthesis results from an approximately
10-fold increase in mRNA half-life; (iv) the inclusion of a
hairpin in the 50UTR of the GPI-PLC mRNA is sufficient
to block translation, but does not stabilize the GPI-PLC
mRNA in procyclics; (v) a GPI-PLC mRNA with a stop
codon in place of codon 15 is not subject to nonsense-
mediated decay but is not stabilized in procyclic forms.
The steady-state amount of any mRNA in a particular cell
will be determined by the rate of synthesis and the rate of
decay. Phosphorimager measurements of the amount of any
mRNA are standardized against rRNA to allow for differences
in the amount of RNA loaded in each gel. This step effectively
converts the estimate of mRNA amount into a concentration,
and thus the measurements of steady-state levels are affected
by the cell volume and ribosome density. In trypanosomes, the
relative abundance of the same mRNA in the two life cycle
stages will be affected by: (i) relative transcription rate, which
is probably higher in bloodstream forms grown at 37C than in
procyclic forms grown at 27C; (ii) cell volume, procyclic
forms are roughly twice the volume of bloodstream forms
(iii) ribosome density, no comparison of ribosomal content
of the two cell types has been reported and (iv) mRNA
Figure 6. Comparison of GPI-PLC expression from transgenes. RNA from both bloodstream (B) and procyclic (P) forms of the same cell lines was analysed by
northern blotting. The probe is indicated under each blot. One clone containing a wild-type GPI-PLC transgene was compared with two independent clones of each of
two cell lines containing either GPI-PLC with a hairpin in the 50UTR or GPI-PLC with a stop codon replacing codon 15. GPI-PLC +/+ and +/ bloodstream form
RNA is shown for comparison, rRNA was used as a loading control and RNA size standards are shown.
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half-life. The considerations other than half-life become
apparent when a constitutive expressed mRNA is analysed.
The actin mRNA is equally abundant in bloodstream and
procyclic forms (54), but the half-life in bloodstream forms
(31) is several-fold shorter than in procyclic forms (27). Pre-
sumably, the difference in half-life is necessary to compensate
for the higher transcription rate and smaller cell volume of
bloodstream forms.
The steady-state level of GPI-PLC mRNA is 50-fold higher
in bloodstream than in procyclic forms. It is probable that this
difference in steady-state levels can be accounted for by a half-
life that is 10-fold greater in bloodstream forms combined with
the effect of the higher transcription rate in and smaller volume
of bloodstream forms, both factors amplifying the difference
in steady-state levels. There is an interesting problem to be
addressed in the future: why the low level of GPI-PLC mRNA
in procyclic forms produces no detectable GPI-PLC activity
(36). The possible explanations are that there is translational
control of the mRNA in procyclic forms and/or the GPI-PLC
protein has a short half-life.
At least two GPI-PLC mRNAs were usually detected on a
northern blot; the predominant band of 3.6 kb corresponds to
the mature mRNA, whereas the precise origin of all of the
larger GPI-PLC mRNAs is less clear. All originate from the
single GPI-PLC gene present in heterozygotes (Figure 6) and
so do not represent allelic variants. One of the larger GPI-PLC
mRNAs results from the use of an alternative trans-splicing
site in the 50UTR and can be reproduced by transferring
the sequence to a reporter gene (H. Webb and M. Carrington,
submitted). It is not clear whether the different GPI-PLC
mRNAs represent different mature mRNAs resulting from
the use of alternative trans-splicing and/or polyadenyla-
tion sites, or whether the larger mRNAs are partially processed
precursors that are yet to complete maturation to the final
GPI-PLC mRNA. After sinefungin treatment, the turnover
rate of the different GPI-PLC mRNAs is not the same
(Figures 1a and 3) and the major, 3.6 kb, mRNA is turned
over more rapidly than the larger forms, either it has a
longer half-life or the larger mRNA are precursors of the
3.6 kb mRNA.
The GPI-PLC mRNA is unstable in procyclic forms with a
half-life of 3 min. Inhibition of protein synthesis increases the
half-life to 30 min. Previously, it had been shown that inhibi-
tion of protein synthesis in bloodstream forms led to accumu-
lation of the normally unstable EP procyclin mRNA (32–34)
as fully mature and polysome-associated mRNA (33). The
GPI-PLC mRNA that accumulates after protein synthesis
inhibitor treatment appears to be fully processed, judged by
mobility after northern blotting. The stabilization of GPI-PLC
mRNA after treatment with cycloheximide indicated that the
normal rapid turnover of the mRNA is translation dependent.
The two possibilities were that the translation of the GPI-PLC
mRNA itself is necessary for the rapid turnover or that trans-
lation of another mRNA is necessary and that the polypeptide
product is effective for only a very short period. To distinguish
between these two possibilities the translation of the GPI-PLC
mRNA was blocked in two ways: the insertion of a hairpin in
the 50UTR or the inclusion of a premature stop codon. The
production of an mRNA from each of the transgenes was
verified in bloodstream forms, all produced readily detectable
mRNA but only the wild-type transgene produced detectable
GPI-PLC protein. The cell lines were differentiated to procyc-
lic forms and the expression from the transgenes determined.
This step contained the assumption that the GPI-PLC mRNA
with a hairpin in the 50UTR was also blocked for translation in
procyclic forms, but it is unlikely that this would be affected
by developmental stage.
In many eukaryotes, mRNAs that are not translated are
degraded by the nonsense-mediated decay pathway (55),
but this pathway did not appear to act on the GPI-PLC
mRNA containing a premature stop codon. Neither the inclu-
sion of the premature stop codon, which allowed translation as
far as codon 14, nor a hairpin in the 50UTR designed to prevent
ribosome assembly on the initiation codon stabilized the GPI-
PLC mRNA in procyclic forms. Thus, the rapid turnover of the
GPI-PLC mRNA in procyclic forms is dependent on the trans-
lation of an mRNA other than GPI-PLC mRNA itself and the
cycloheximide is acting in trans.
Only one other example of dependency of the rapid turn-
over of an mRNA on the translation of a trans-acting factor
has been unambiguously demonstrated. In mammalian cells,
the transferrin receptor (TfR) mRNA is stable when cells are
depleted of iron but degraded when iron is plentiful. The
rapid turnover of the TfR mRNA that occurs in the presence
of iron can be blocked by the addition of cycloheximide
(56). The action of the cycloheximide is to block the turn-
over of the trans-acting factor IRP-2, which along with a
second trans-acting factor, IRP-1, probably stabilizes the
TfR mRNA by binding to iron responsive elements within
the 30UTR. The labile factor affected by cycloheximide
could be necessary for targeting IRP-2 to the proteosome
as treatment with the proteosome inhibitor MG132 also
stabilized the TfR mRNA (56).
In other examples, where rapid mRNA turnover can be
blocked by protein synthesis inhibitors, it is the translation
of the mRNA that is necessary for turnover. In the case of
b-tubulin mRNA, a polysome-associated nuclease is involved
(57). The c-fos mRNA is unstable and the turnover regulated
by AU-rich elements (AREs) in the 30UTR and by protein
coding region determinants. Blocking translation of the
major coding region determinant by the inclusion of a stem
loop stabilizes the mRNA (58,59). In yeast, the turnover path-
way followed by mRNAs containing AREs involves a short-
ening in poly A tail length followed by removal of the 50 cap
and subsequent hydrolysis by a 50 to 30 exonuclease. Trans-
acting factors bound to AREs are believed to modulate the rate
at which deadenylation occurs though whether translation of
the mRNA itself is necessary for deadenylation is not clear
[reviewed in (60) and (61)]. The U-rich elements identified in
the 30UTRs of unstable mRNAs in trypanosomes are believed
to function in a similar manner to AREs (22,28), but at this
stage it is not known whether any cis-acting sequences in the
GPI-PLC mRNA are similar to U-rich elements.
In conclusion, it has been shown that the developmentally
regulated expression of the GPI-PLC gene in trypanosomes
can be accounted for by the regulation of mRNA half-life and
that the rapid turnover of the GPI-PLC mRNA in procyclic
form trypanosomes is dependent on the continuous translation
of a trans-acting factor. The dependency of the rapid turnover
of the GPI-PLC mRNA in trypanosomes and TfR mRNA in
mammalian cells on a labile factor suggests the presence of an
evolutionarily conserved pathway and a better understanding
1510 Nucleic Acids Research, 2005, Vol. 33, No. 5
of the pathway in the future will come from the identification
of its components.
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